Verve Therapeutics (VERV)
(Real Time Quote from BATS)
$6.20 USD
-0.08 (-1.27%)
Updated Jul 10, 2024 10:34 AM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Verve Therapeutics, Inc. [VERV]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
VERVE-102 Phase 1b Trial Underway; 1Q24 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
Don''t Have a Heart Attack; Base Editing Platform; Initiate at Buy and $15 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Verve Therapeutics, Inc.
Industry: Medical - Drugs
Optimized Entry and Exit Levels for VERV 112223
Provider: Stock Traders Daily
Analyst: Research Department
|